News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Centrex, Inc. Names Jeffrey Flannery Chief Business Development Officer


10/19/2005 5:09:18 PM

Centrex, Inc. (OTCBB:CNEX) today announced that Jeffrey Flannery has been named as the Company's Chief Business Development Officer. Mr Flannery will assume and expand upon some of the duties currently undertaken by Centrex CEO Dr. Thomas R. Coughlin, Jr. Dr. Coughlin will continue as CEO and Chief Science Officer and will concentrate his efforts on supervising the commercialization of the Centrex Single Molecule Nucleic Acid Detection (SMD) technology.

Read at BioSpace.com

comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES